Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00581217 · ClinicalTrials.gov registry record
A Randomized Comparison Study of Aquacel Ag and Glucan II as Donor Site Dressings
A clinical trial, sponsored by University of California, Irvine.
- Terminated
- Registry status
- 20
- Enrollment target
NCT00581217 is a clinical trial that was terminated before completion, run by University of California, Irvine. The registered enrollment target is 20 participants.
The verdict
NCT00581217 was terminated before completion, sponsored by University of California, Irvine.
- TERMINATED
- Registry status
- 20 participants
- Enrollment target
Study Summary
The research will be looking at patient outcomes for healing of donor sites after a split-thickness skin graft procedure for a burn or skin tissue loss. Donor site healing time, infection rate, cosmetic outcome, and patient's rating of pain will be compared between two donor site dressings, Glucan II and Aquacel Ag.
Interventions
- OTHER Aquacel Ag
- OTHER Glucan II
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2007-12 |
| Est. Completion | 2010-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00581217
The ClinicalTrials.gov registry entry for NCT00581217 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Irvine, which has 368 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Aquacel Ag is the first listed.
NCT00581217 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00581217 about?
NCT00581217 is a clinical study titled "A Randomized Comparison Study of Aquacel Ag and Glucan II as Donor Site Dressings". The research will be looking at patient outcomes for healing of donor sites after a split-thickness skin graft procedure for a burn or skin tissue loss. Donor site healing time, infection rate, cosmetic outcome, and patient's rating of pain will be compared between two donor site dressings, Glucan I...
What is the current status of trial NCT00581217?
This trial is currently terminated. The enrollment target is 20 participants. The study started on 2007-12. Estimated completion is 2010-09.
What interventions are being tested in trial NCT00581217?
The interventions under investigation include: Aquacel Ag (OTHER), Glucan II (OTHER).
Who is sponsoring clinical trial NCT00581217?
This trial is sponsored by University of California, Irvine, which has 368 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.